<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id><journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id><journal-title-group><journal-title>BMC Research Notes</journal-title></journal-title-group><issn pub-type="epub">1756-0500</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31358035</article-id><article-id pub-id-type="pmc">6664564</article-id><article-id pub-id-type="publisher-id">4487</article-id><article-id pub-id-type="doi">10.1186/s13104-019-4487-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Note</subject></subj-group></article-categories><title-group><article-title>Estimation of renal function in adult outpatients with normal serum creatinine</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Fiseha</surname><given-names>Temesgen</given-names></name><address><email>temafiseha@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Mengesha</surname><given-names>Tizita</given-names></name><address><email>metizita@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Girma</surname><given-names>Rahel</given-names></name><address><email>richgirma@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Kebede</surname><given-names>Edosa</given-names></name><address><email>edexkebede@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2992-574X</contrib-id><name><surname>Gebreweld</surname><given-names>Angesom</given-names></name><address><email>afsaha@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0515 5212</institution-id><institution-id institution-id-type="GRID">grid.467130.7</institution-id><institution>Department of Clinical Laboratory Science, College of Medicine and Health Sciences, </institution><institution>Wollo University, </institution></institution-wrap>Dessie, Ethiopia </aff></contrib-group><pub-date pub-type="epub"><day>29</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>12</volume><elocation-id>462</elocation-id><history><date date-type="received"><day>7</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>17</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objective</title><p id="Par1">The aim of this study was to estimate the prevalence of renal insufficiency using estimated glomerular filtration rate (eGFR) among adult outpatients with normal SCr.</p></sec><sec><title>Results</title><p id="Par2">A total of 414 patients with normal SCr were included in the study. Mean GFR (ml/min/1.73&#x000a0;m<sup>2</sup>) was 116.8&#x02009;&#x000b1;&#x02009;43.5 using the MDRD equation and 90.5&#x02009;&#x000b1;&#x02009;33.1 by the C&#x02013;G formula. According to the MDRD formula, mild renal insufficiency (i.e. eGFR 60&#x02013;89.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) was found in 21.5% of the patients and moderate renal insufficiency (i.e. eGFR 30&#x02013;59.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) was found in 7.7%. According to the Cockcroft&#x02013;Gault (C&#x02013;G) formula, mild renal insufficiency was found in 38.2% and moderate renal insufficiency in 16.9% of the patients with normal SCr. In multivariate analysis, older age, female sex, a family history of kidney disease or other chronic diseases and high systolic blood pressure were associated with prevalent renal insufficiency depending on the formula used to estimate GFR. This study demonstrates the substantial prevalence of impaired renal function among Ethiopian adult outpatients with normal SCr. Including calculated estimates of GFR in routine laboratory reporting may help to facilitate the identification and thus optimal management of patients with renal insufficiency.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Serum creatinine</kwd><kwd>Renal function</kwd><kwd>Estimated glomerular filtration rate</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par12">Kidney disease, even when renal function is only mildly or moderately altered, is an established risk factor for all-cause and cardiovascular mortality in high-risk patients, as well as in the general population [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]. Impaired renal function is also associated with an increased risk of several complications, such as anemia and bone mineral metabolism disorders, and poor outcomes, including cardiovascular events and progression to renal failure; requiring renal replacement therapy [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. Early detection of renal impairment is, therefore, crucial to facilitate the employment of measures that can prevent or delay disease progression and reduce the risk of adverse outcomes [<xref ref-type="bibr" rid="CR8">8</xref>]. Glomerular filtration rate (GFR) is accepted as the best indicator of renal function in both health and disease. GFR can be measured directly by clearance studies of ideal exogenous markers, such as inulin. However, none of these procedures are practical or economical for routine use and serum levels of endogenous filtration markers have traditionally been used to estimate renal function [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par13">Serum creatinine (SCr) is the most widely used endogenous filtration marker for assessing renal function in clinical practice. However, SCr is insensitive to detect early renal disease, and levels could remain within the normal range even when renal function is significantly impaired; making the recognition and thus the optimal management of renal impairment at earlier stages more difficult [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Current guidelines therefore recommend the use of prediction equations, such as the Modification of Diet in Renal Disease (MDRD) equation [<xref ref-type="bibr" rid="CR12">12</xref>] and the Cockcroft&#x02013;Gault equation [<xref ref-type="bibr" rid="CR13">13</xref>], to estimate GFR (eGFR) whenever SCr is measured to facilitate early recognition of renal disease [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. In agreement with these guidelines, several studies provided evidence that incorporating eGFR into screening for renal impairment would identify individuals earlier in the natural history of the disease and enable the timely initiation of treatment to slow progression of renal disease and improve patient outcomes [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par14">Most outpatient laboratories in Ethiopia do not routinely report estimated GFR when SCr is measured, and renal function is usually estimated by inspection of SCr levels in the primary care settings. Despite this, the under-ascertainment of impaired renal function among the Ethiopian adult outpatients with normal SCr has not been reported. Such information will be useful in establishing the clinical relevance and need of providing automated eGFR reporting for adult outpatients in the country. The aim of this study was to determine the prevalence of renal insufficiency using estimated GFR (eGFR) among adult outpatients with normal SCr at a hospital in Northeast Ethiopia.</p></sec><sec id="Sec2"><title>Main text</title><sec id="Sec3"><title>Methods</title><sec id="Sec4"><title>Study design, setting and population</title><p id="Par15">This cross-sectional study was conducted at the out-patient department of Debre Berhan Referral Hospital in North Shoa zone of Amhara regional state, which is located 130&#x000a0;km north of the capital Addis Ababa, Ethiopia. Adult outpatients (aged 18&#x000a0;years or more) referred by physicians for SCr measurements during the period from January to April 2018 were included in the study. Patients were excluded if they were treated with dialysis, hospitalized, have acute illnesses (fever) and if their SCr levels were abnormal (men&#x02009;&#x0003e;&#x02009;1.5&#x000a0;mg/dl and women&#x02009;&#x0003e;&#x02009;1.3&#x000a0;mg/dl). After applying exclusion criteria, 422 consecutive patients with normal SCr were qualified for the study.</p></sec><sec id="Sec5"><title>Sample size determination</title><p id="Par16">The sample size was calculated using single proportion formula on the basis of the following assumptions: a 95% confidence level; 5% margin of error; expected renal impairment prevalence of 50% and by adding 10% non-response rate. Respondents who did not participate in the examination component (n&#x02009;=&#x02009;8) were excluded from the analysis. The final sample therefore included 414 individuals.</p></sec><sec id="Sec6"><title>Data collection</title><p id="Par17">Participants were interviewed for collecting demographic and other risk factor variables. Weight, height and blood pressure were measured at the time of the clinical examination performed. Body mass index (BMI) was calculated as weight square (kg) to height (meters), and participants were grouped into normal (BMI&#x02009;&#x0003c;&#x02009;25&#x000a0;kg/m<sup>2</sup>), overweight (BMI&#x02009;=&#x02009;25&#x02013;29.9&#x000a0;kg/m<sup>2</sup>) and obese (BMI&#x02009;&#x02265;&#x02009;30&#x000a0;kg/m<sup>2</sup>). Blood pressure (BP) was measured in the right upper arm in the sitting posture, after a 5&#x000a0;min rest and three measurements were averaged. Hypertension was defined as systolic BP&#x02009;&#x02265;&#x02009;140&#x000a0;mmHg and/or diastolic BP&#x02009;&#x02265;&#x02009;90&#x000a0;mmHg and/or use of antihypertensive medication. A blood sample was collected for SCr measurement using a modified Jaffe method as mg/dl with calibration traceable to IDMS reference material NIST SRM 909B level 2.</p></sec><sec id="Sec7"><title>Measurement of renal function</title><p id="Par18">Renal function was estimated according to the 4-variable Modification of Diet in Renal Disease (MDRD) study equation as eGFR&#x02009;=&#x02009;186&#x02009;&#x000d7;&#x02009;SCr (mg/dl)<sup>&#x02212;1.154</sup>&#x02009;&#x000d7;&#x02009;age (years)<sup>&#x02212;0.203</sup>&#x02009;&#x000d7;&#x02009;0.742 (if female)&#x02009;&#x000d7;&#x02009;1.210 (if black) [<xref ref-type="bibr" rid="CR12">12</xref>] and the Cockcroft&#x02013;Gault (C&#x02013;G) formula [<xref ref-type="bibr" rid="CR13">13</xref>] normalized for the body surface area (BSA): (140-age)&#x02009;&#x000d7;&#x02009;Weight (kg)&#x02009;&#x000d7;&#x02009;0.86 (if female)&#x02009;&#x000d7;&#x02009;1.73/72&#x02009;&#x000d7;&#x02009;SCr (mg/dl)&#x02009;&#x000d7;&#x02009;BSA (m<sup>2</sup>). Patients were categorized as having normal renal function when the eGFR was &#x02265;&#x02009;90&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>, and mild, moderate and severe renal insufficiency when the eGFR was 60&#x02013;89.9, 30&#x02013;59.9 and 15&#x02013;29.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>, respectively [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Moderate renal insufficiency was further categorized into G3a (eGFR 45&#x02013;59.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) and G3b (eGFR 30&#x02013;44.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) [<xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec8"><title>Statistical analysis</title><p id="Par19">Statistical analyses were carried out using SPSS version 20.0 software (SPSS Inc., Chicago, IL, USA). Data were expressed as mean&#x02009;&#x000b1;&#x02009;standard deviation (SD) or percentage. Comparisons between groups were done by Chi square (x<sup>2</sup>) test or <italic>t</italic>-test as appropriate. Multivariate logistic regression was conducted and the corresponding adjusted odds ratios (AOR) and 95% confidence intervals (CI) were used to identify factors independently associated with renal insufficiency. <italic>P&#x02009;</italic>&#x0003c;&#x02009;0.05 was used to indicate statistical significance.</p></sec></sec><sec id="Sec9"><title>Results</title><p id="Par20">A total of 414 patients who had SCr level within the normal range participated in this study. Mean age was 48.9&#x02009;&#x000b1;&#x02009;17&#x000a0;years, and 216 (52.2%) were males. Of the total participants, 83 (20.0%) were diabetic, 89 (21.5%) were hypertensive, 32 (7.7%) had cardiovascular disease and 29 (7.0%) were HIV positive patients. Majority, 372 (89.9%) of the participants had no a family history of kidney disease (FH-KD). Mean BMI was 21.82&#x02009;&#x000b1;&#x02009;2.56&#x000a0;kg/m<sup>2</sup>. Mean systolic and diastolic BP (mmHg) were 124&#x02009;&#x000b1;&#x02009;12 and 79&#x02009;&#x000b1;&#x02009;10, respectively. Mean SCr was 0.88&#x02009;&#x000b1;&#x02009;0.26&#x000a0;mg/dl. The mean eGFR (ml/min/1.73&#x000a0;m<sup>2</sup>) of the participants were 116.8&#x02009;&#x000b1;&#x02009;43.5 and 90.5&#x02009;&#x000b1;&#x02009;33.1 according to the MDRD and C&#x02013;G equations, respectively (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Demographic and clinical characteristics of study subjects with normal serum creatinine (n&#x02009;=&#x02009;414)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristics</th><th align="left"/></tr></thead><tbody><tr><td align="left">Age (year), mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">48.9&#x02009;&#x000b1;&#x02009;17</td></tr><tr><td align="left" colspan="2">Age group, n (%)</td></tr><tr><td align="left">&#x000a0;18&#x02013;30</td><td align="left">84 (20.3)</td></tr><tr><td align="left">&#x000a0;31&#x02013;40</td><td align="left">71 (17.1)</td></tr><tr><td align="left">&#x000a0;41&#x02013;50</td><td align="left">69 (16.7)</td></tr><tr><td align="left">&#x000a0;51&#x02013;60</td><td align="left">79 (19.1)</td></tr><tr><td align="left">&#x000a0;&#x0003e;&#x02009;60</td><td align="left">111 (26.8)</td></tr><tr><td align="left" colspan="2">Sex, n (%)</td></tr><tr><td align="left">&#x000a0;Male</td><td align="left">216 (52.2)</td></tr><tr><td align="left">&#x000a0;Female</td><td align="left">198 (47.8)</td></tr><tr><td align="left" colspan="2">Education, n (%)</td></tr><tr><td align="left">&#x000a0;&#x0003c;&#x02009;High school</td><td align="left">292 (70.5)</td></tr><tr><td align="left">&#x000a0;&#x02265;&#x02009;High school</td><td align="left">122 (29.5)</td></tr><tr><td align="left" colspan="2">Family history, n (%)</td></tr><tr><td align="left">&#x000a0;Kidney disease</td><td align="left">42 (10.1)</td></tr><tr><td align="left">&#x000a0;Hypertension, diabetes or CVD</td><td align="left">90 (21.7)</td></tr><tr><td align="left" colspan="2">Medical history, n (%)</td></tr><tr><td align="left">&#x000a0;Diabetes</td><td align="left">83 (20.0)</td></tr><tr><td align="left">&#x000a0;Hypertension</td><td align="left">89 (21.5)</td></tr><tr><td align="left">&#x000a0;Cardiovascular disease</td><td align="left">32 (7.7)</td></tr><tr><td align="left">&#x000a0;HIV</td><td align="left">29 (7.0)</td></tr><tr><td align="left">Current smoker, n (%)</td><td align="left">23 (5.6)</td></tr><tr><td align="left">Body mass index (Kg/m<sup>2</sup>), mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">21.82&#x02009;&#x000b1;&#x02009;2.56</td></tr><tr><td align="left">Systolic BP (mmHg), mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">124&#x02009;&#x000b1;&#x02009;12</td></tr><tr><td align="left">Diastolic BP (mmHg), mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">79&#x02009;&#x000b1;&#x02009;10</td></tr><tr><td align="left">Serum creatinine (mg/dl), mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">0.88&#x02009;&#x000b1;&#x02009;0.26</td></tr><tr><td align="left">eGFR<sub>MDRD</sub> (ml/min/1.73&#x000a0;m<sup>2</sup>), mean&#x02009;&#x000b1;&#x02009;SD)</td><td align="left">116.8&#x02009;&#x000b1;&#x02009;43.5</td></tr><tr><td align="left">eGFR<sub>C&#x02013;G</sub> (ml/min/1.73&#x000a0;m<sup>2</sup>), mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">90.5&#x02009;&#x000b1;&#x02009;33.1</td></tr></tbody></table><table-wrap-foot><p>BP blood pressure, <italic>CVD</italic> cardiovascular disease, <italic>eGFR</italic> estimated glomerular filtration rate</p></table-wrap-foot></table-wrap>
</p><p id="Par21">Estimation of renal function in patients with normal SCr using the MDRD and C&#x02013;G equations are presented in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. In patients with normal SCr, according to the MDRD equation mild renal insufficiency (eGFR 60&#x02013;89.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) was found in 21.5% of the patients and moderate renal insufficiency (eGFR 30&#x02013;59.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) was found 7.7%. According to the C&#x02013;G formula, mild renal insufficiency was found in 38.2% of the patients and moderate renal insufficiency (eGFR 30&#x02013;44.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) was found in 16.9% of the patients with normal SCr. Thirty-two (7.7%) and 38 (9.2%) of patients with normal SCr had mild to moderately impaired renal function (eGFR 45&#x02013;59.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) according to the MDRD and C&#x02013;G equations, respectively. In addition, 32 (7.7%) patients had moderate to severely impaired renal function (eGFR 30&#x02013;44.9&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) despite normal SCr when renal function was estimated using the C&#x02013;G formula (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Estimation of renal function in patients with normal serum creatinine using the simplified MDRD and Cockcroft&#x02013;Gault formulas</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">GFR (ml/min/1.73&#x000a0;m<sup>2</sup>)</th><th align="left">Description</th><th align="left">MDRD, n (%)</th><th align="left">Cockcroft&#x02013;Gault, n (%)</th></tr></thead><tbody><tr><td align="left">&#x02265;&#x02009;90</td><td align="left">Normal or high GFR</td><td align="left">293 (70.8)</td><td char="(" align="char">186 (44.9)</td></tr><tr><td align="left">60&#x02013;89.9</td><td align="left">Mildly &#x02193; GFR</td><td align="left">89 (21.5)</td><td char="(" align="char">158 (38.2)</td></tr><tr><td align="left">30&#x02013;59.9</td><td align="left">Moderate &#x02193; GFR</td><td align="left">32 (7.7)</td><td char="(" align="char">70 (16.9)</td></tr><tr><td align="left">45&#x02013;59.9</td><td align="left">Mild to moderate &#x02193; GFR</td><td align="left">32 (7.7)</td><td char="(" align="char">38 (9.2)</td></tr><tr><td align="left">30&#x02013;44.9</td><td align="left">Moderate to severe &#x02193; GFR</td><td align="left">&#x02013;</td><td char="(" align="char">32 (7.7)</td></tr></tbody></table><table-wrap-foot><p><italic>GFR</italic> glomerular filtration rate</p></table-wrap-foot></table-wrap>
</p><p id="Par22">Characteristics of patients with and without clinically significant renal insufficiency (eGFR&#x02009;&#x0003c;&#x02009;60&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) according to the MDRD equation are shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. Patients with renal insufficiency were significantly older, females, had low educational status, family history of kidney disease or other chronic disease (diabetes, hypertension or CVD), medical history of hypertension, high systolic and diastolic BP, higher BMI and SCr when compared with patients with eGFR &#x02265;&#x02009;60&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>. Except for gender and BMI, the same pattern was found when C&#x02013;G formula was used.<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Characteristics of patients with and without renal insufficiency (eGFR <sub>MDRD</sub>&#x02009;&#x0003c;&#x02009;60&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">eGFR&#x02009;&#x0003c;&#x02009;60&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup></th><th align="left">eGFR&#x02009;&#x02265;&#x02009;60&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup></th></tr></thead><tbody><tr><td align="left">Age above 60&#x000a0;years<sup>b</sup>, %</td><td align="left">68.8</td><td align="left">23.3</td></tr><tr><td align="left">Female sex<sup>b</sup>, %</td><td align="left">90.6</td><td align="left">44.2</td></tr><tr><td align="left">Education: &#x0003c;&#x02009;High school<sup>a</sup>, %</td><td align="left">87.5</td><td align="left">69.1</td></tr><tr><td align="left" colspan="3">Family history, %</td></tr><tr><td align="left">&#x000a0;Kidney disease<sup>b</sup></td><td align="left">28.1</td><td align="left">8.4</td></tr><tr><td align="left">&#x000a0;HTN, DM or CVD<sup>b</sup></td><td align="left">50.0</td><td align="left">19.4</td></tr><tr><td align="left">Medical history, n (%)</td><td align="left"/><td align="left"/></tr><tr><td align="left">&#x000a0;Hypertension<sup>a</sup></td><td align="left">43.8</td><td align="left">19.6</td></tr><tr><td align="left">&#x000a0;Diabetes mellitus</td><td align="left">31.2</td><td align="left">19.1</td></tr><tr><td align="left">&#x000a0;Cardiovascular disease</td><td align="left">9.4</td><td align="left">7.6</td></tr><tr><td align="left">&#x000a0;HIV</td><td align="left">6.2</td><td align="left">7.1</td></tr><tr><td align="left">Current smoker</td><td align="left">9.4</td><td align="left">5.2</td></tr><tr><td align="left">Antihypertensive drug intake<sup>b</sup>, %</td><td align="left">40.6</td><td align="left">13.6</td></tr><tr><td align="left">Systolic BP (mm Hg)<sup>b</sup></td><td align="left">134.1&#x02009;&#x000b1;&#x02009;11.60</td><td align="left">123.2&#x02009;&#x000b1;&#x02009;11.56</td></tr><tr><td align="left">Diastolic BP (mm Hg)<sup>b</sup></td><td align="left">85.6&#x02009;&#x000b1;&#x02009;8.51</td><td align="left">78.7&#x02009;&#x000b1;&#x02009;9.52</td></tr><tr><td align="left">Hypertension<sup>b</sup>, n (%)</td><td align="left">65.6</td><td align="left">27.5</td></tr><tr><td align="left">BMI (kg/m<sup>2</sup>)<sup>a</sup></td><td align="left">22.87&#x02009;&#x000b1;&#x02009;3.0</td><td align="left">21.73&#x02009;&#x000b1;&#x02009;2.5</td></tr><tr><td align="left">Serum creatinine (mg/dl)<sup>b</sup></td><td align="left">1.34&#x02009;&#x000b1;&#x02009;0.07</td><td align="left">0.84&#x02009;&#x000b1;&#x02009;0.23</td></tr><tr><td align="left">eGFR (ml/min/1.73&#x000a0;m<sup>2</sup>)<sup>b</sup></td><td align="left">52.34&#x02009;&#x000b1;&#x02009;2.65</td><td align="left">122.19&#x02009;&#x000b1;&#x02009;40.91</td></tr></tbody></table><table-wrap-foot><p><italic>HTN</italic> hypertension, <italic>DM</italic> diabetes mellitus, <italic>CVD</italic> cardiovascular disease, <italic>BP</italic> blood pressure, <italic>BMI</italic> body mass index, <italic>eGFR</italic> estimated glomerular filtration rate</p><p><sup>a</sup>Differences or associations significant at <italic>P&#x02009;</italic>&#x0003c;&#x02009;0.05</p><p><sup>b</sup>Differences or associations significant at <italic>P&#x02009;</italic>&#x0003c;&#x02009;0.001</p></table-wrap-foot></table-wrap>
</p><p id="Par23">In multivariate analysis, older age (AOR&#x02009;=&#x02009;10.81, 95% CI 4.05&#x02013;28.83, <italic>P&#x02009;</italic>&#x0003c;&#x02009;<italic>0</italic>.001), female sex (AOR&#x02009;=&#x02009;32.00, 95% CI 7.99&#x02013;128.13; <italic>P&#x02009;</italic>&#x0003c;&#x02009;<italic>0</italic>.001), a family history of other chronic diseases (AOR&#x02009;=&#x02009;3.06, 95% CI 1.19&#x02013;7.86, <italic>P&#x02009;</italic>=&#x02009;<italic>0</italic>.020), and high systolic BP (AOR&#x02009;=&#x02009;1.07, 95% CI 1.03&#x02013;1.12, <italic>P&#x02009;</italic>=&#x02009;<italic>0</italic>.002) were independently associated with increased risk of renal insufficiency according to the MDRD equation. However, only older age (AOR&#x02009;=&#x02009;14.06, 95% CI 7.39&#x02013;26.77; <italic>P&#x02009;</italic>&#x0003c;&#x02009;<italic>0</italic>.001) and a FH-KD (AOR&#x02009;=&#x02009;2.80, 95% CI 1.21&#x02013;6.48, <italic>P&#x02009;</italic>=&#x02009;<italic>0</italic>.017) were independently associated with prevalent renal insufficiency when using C&#x02013;G formula.</p></sec><sec id="Sec10"><title>Discussion</title><p id="Par24">In this study, we found a high prevalence of abnormal renal function up to 55% on the basis of eGFR in adult out-patient with normal SCr. Clinically significant renal insufficiency (as defined by eGFR&#x02009;&#x0003c;&#x02009;60&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) was found in 7.7&#x02013;16.9% of the study participants depending on the formula used to estimate GFR. In previous studies, a considerable number of out-patients ranging from 5.3 to 19.3% have shown to have significantly impaired renal function (eGFR&#x02009;&#x0003c;&#x02009;60&#x000a0;ml/min/1.73&#x000a0;m<sup>2</sup>) with normal SCr [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>]. Another study also found that 13.9% of out-patients with normal range SCr levels had substantially abnor-mal calculated GFR, with C&#x02013;G values&#x02009;&#x0003c;&#x02009;50&#x000a0;ml/min [<xref ref-type="bibr" rid="CR10">10</xref>]. These findings suggest that if SCr is used instead of eGFR as a measure of renal function, there is a likely chance of missing a significant number of patients with renal insufficiency.</p><p id="Par25">This study shows that a large proportion of females and older persons with impaired renal function are not diagnosed if clinicians rely only on normal SCr levels as evidence of normal renal function. This is supported by the results of related studies and by the fact that SCr production is dependent on lean body mass and therefore may not be an accurate reflection of GFR, especially in older subjects and females because they have a reduced muscle mass [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>]. The above studies have also demonstrated that inclusion of eGFR calculated by using equations which attempt to correct for factors affecting the muscle mass, such as age, sex and body size may facilitates the early identification and intervention of these subgroup of patients with renal impairment.</p><p id="Par26">The finding of significantly prevalent renal insufficiency in patients with a FH-KD, a family history of other chronic diseases (diabetes, hypertension or CVD) and high systolic BP, suggests that a substantial proportion of cardiovascular at risk patients whose SCr levels fall within the normal range would not have been identified as having abnormal renal function without use of the GFR equations to estimate renal function. This is consistent with previous findings which documented that renal function should be assessed by using eGFR than SCr alone to facilitate the identification of high-risk patients with renal insufficiency at a time sufficient to ensure proactive care to delay disease progression and improve outcomes [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. This was also supported by the NKF K/DOQI guidelines, which recommend using a GFR estimating equations to derive GFR from SCr (eGFR) rather than relying on SCr alone in at-risk populations [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p id="Par27">Estimates of GFR using prediction equations provide substantial improvements over the measurement of SCr alone in the clinical assessment of renal function [<xref ref-type="bibr" rid="CR31">31</xref>]. Several creatinine-based GFR prediction equations were developed in the past for estimating renal function, but the most commonly used are the MDRD [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR32">32</xref>] and the C&#x02013;G equations [<xref ref-type="bibr" rid="CR13">13</xref>]. The MDRD equation that was developed using data from patients with established renal insufficiency as measured by <sup>125</sup>I-iothalamate clearance adjusted for BSA is the most widely used in clinical practice today. Since it relies on age, sex, race and SCr only, this equation is quick and easy to calculate on all patients using data routinely provided when requesting a SCr measurement. It has been generally shown to provide a more accurate estimates of GFR than measured creatinine clearance or the C&#x02013;G equation [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. The C&#x02013;G equation, which predicts creatinine clearance [<xref ref-type="bibr" rid="CR13">13</xref>], is a simple and recommended means to assess renal function. Unlike the MDRD equation, it requires a measure of height and computation of BSA (making it a less convenient method for routine use). However, eGFR derived from the C&#x02013;G equation is superior to SCr alone in the assessment of renal function [<xref ref-type="bibr" rid="CR33">33</xref>].</p></sec><sec id="Sec11"><title>Conclusions</title><p id="Par28">In conclusion, this study demonstrates a substantial prevalence of renal impairment among Ethiopian adult outpatients identified as having normal SCr levels. A large proportion of the elderly, women and cardiovascular at risk patients will not be recognized as having impaired renal function if clinicians rely on normal SCr as evidence of normal renal function. Including calculated estimates of GFR in routine laboratory reporting may help to facilitate the early identification and thus optimal management of patients with renal impairment.</p></sec></sec><sec id="Sec12"><title>Limitations</title><p id="Par29">The use of calculated GFR but not measured GFR, which is not the gold standard, to estimate renal function is the first limitation. Secondly, we used the MDRD study equation, the validation of which is lacking among Ethiopian adults. Third, the measurement of serum creatinine was not standardized; this might influence the performance of eGFR equations, particularly at higher values. This also limited us from using the popular Chronic Kidney Disease Epidemiology (CKD&#x02013;EPI) equation, as recommended by the KDIGO guidelines. Finally, the estimation of abnormal GFR is based on a single measurement of SCr which might lead to over or under estimating patients with abnormal GFR.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AOR</term><def><p id="Par3">adjusted odds ratio</p></def></def-item><def-item><term>BMI</term><def><p id="Par4">body mass index</p></def></def-item><def-item><term>BP</term><def><p id="Par5">blood pressure</p></def></def-item><def-item><term>C&#x02013;G</term><def><p id="Par6">Cockcroft&#x02013;Gault</p></def></def-item><def-item><term>CI</term><def><p id="Par7">confidence interval</p></def></def-item><def-item><term>eGFR</term><def><p id="Par8">estimated glomerular filtration rate</p></def></def-item><def-item><term>FH-KD</term><def><p id="Par9">family history of kidney disease</p></def></def-item><def-item><term>GFR</term><def><p id="Par10">glomerular filtration rate</p></def></def-item><def-item><term>MDRD</term><def><p id="Par11">modification of diet in renal disease</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to acknowledge data collectors, and staff of Debre Berhan Referral Hospital for collecting the data.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>TF and AG were involved in the conception, design, analysis, interpretation, report writing and manuscript writing. TM, RG and EK had been involved in the design, analysis, and critically reviewing the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study did not receive any official funding.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The date of this study can&#x02019;t be shared publicly due to presence of sensitive (confidential) participants&#x02019; information and additional data than that used in this publication. But the data are available from the corresponding author on reasonable request.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par30">Study protocol was approved by the Institutional Review Board of College of Medicine and Health Sciences, Wollo University. An informed verbal as well as written consent was obtained from each study participants. Moreover, confidentiality was assured for all the information provided and personal identifiers were not included on questionnaire.</p></notes><notes><title>Consent for publication</title><p id="Par31">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par32">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>RM</given-names></name><name><surname>Kostense</surname><given-names>PJ</given-names></name><name><surname>Bos</surname><given-names>G</given-names></name><name><surname>Dekker</surname><given-names>JM</given-names></name><name><surname>Nijpels</surname><given-names>G</given-names></name><name><surname>Heine</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study</article-title><source>Kidney Int</source><year>2002</year><volume>62</volume><fpage>1402</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1755.2002.kid571.x</pub-id><pub-id pub-id-type="pmid">12234312</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Hamm</surname><given-names>L</given-names></name><name><surname>Loria</surname><given-names>C</given-names></name><name><surname>Whelton</surname><given-names>PK</given-names></name></person-group><article-title>Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States</article-title><source>J Am Soc Nephrol</source><year>2002</year><volume>13</volume><fpage>745</fpage><lpage>753</lpage><pub-id pub-id-type="pmid">11856780</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leoncini</surname><given-names>G</given-names></name><name><surname>Viazzi</surname><given-names>F</given-names></name><name><surname>Parodi</surname><given-names>D</given-names></name><name><surname>Ratto</surname><given-names>E</given-names></name><name><surname>Vettoretti</surname><given-names>S</given-names></name><name><surname>Vaccaro</surname><given-names>V</given-names></name><etal/></person-group><article-title>Mild renal dysfunction and cardiovascular risk in hypertensive patients</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><fpage>S88</fpage><lpage>S90</lpage><pub-id pub-id-type="doi">10.1097/01.ASN.0000093245.78097.CD</pub-id><pub-id pub-id-type="pmid">14684681</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Baek</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>YC</given-names></name><name><surname>Goo</surname><given-names>HS</given-names></name><name><surname>Heo</surname><given-names>NJ</given-names></name><name><surname>Na</surname><given-names>KY</given-names></name><etal/></person-group><article-title>Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population</article-title><source>Nephrol Dial Transpl.</source><year>2012</year><volume>27</volume><fpage>2284</fpage><lpage>2290</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfr622</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inker</surname><given-names>LA</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Tonelli</surname><given-names>M</given-names></name><name><surname>Muntner</surname><given-names>P</given-names></name></person-group><article-title>Estimated GFR, albuminuria, and complications of chronic kidney disease</article-title><source>J Am Soc Nephrol</source><year>2011</year><volume>22</volume><fpage>2322</fpage><lpage>2331</lpage><pub-id pub-id-type="doi">10.1681/ASN.2010111181</pub-id><pub-id pub-id-type="pmid">21965377</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manjunath</surname><given-names>G</given-names></name><name><surname>Tighiouart</surname><given-names>H</given-names></name><name><surname>Ibrahim</surname><given-names>H</given-names></name><name><surname>MacLeod</surname><given-names>B</given-names></name><name><surname>Salem</surname><given-names>DN</given-names></name><name><surname>Griffith</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community</article-title><source>J Am Coll Cardiol</source><year>2003</year><volume>41</volume><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(02)02663-3</pub-id><pub-id pub-id-type="pmid">12570944</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>WY</given-names></name><name><surname>Kong</surname><given-names>APS</given-names></name><name><surname>Ma</surname><given-names>RCW</given-names></name><name><surname>Ozaki</surname><given-names>R</given-names></name><name><surname>Szeto</surname><given-names>CC</given-names></name><name><surname>Chan</surname><given-names>NN</given-names></name><etal/></person-group><article-title>Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><fpage>2046</fpage><lpage>2052</lpage><pub-id pub-id-type="doi">10.2337/dc06-0248</pub-id><pub-id pub-id-type="pmid">16936151</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DW</given-names></name></person-group><article-title>Evidence-based guide to slowing the progression of early renal insufficiency</article-title><source>Intern Med J.</source><year>2004</year><volume>34</volume><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1111/j.1444-0903.2004.t01-6-.x</pub-id><pub-id pub-id-type="pmid">14748914</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesley</surname><given-names>A</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Andrew</surname><given-names>S</given-names></name></person-group><article-title>Assessing kidney function&#x02014;measured and estimated glomerular filtration rate</article-title><source>N Engl J Med</source><year>2006</year><volume>354</volume><fpage>2473</fpage><lpage>2483</lpage><pub-id pub-id-type="doi">10.1056/NEJMra054415</pub-id><pub-id pub-id-type="pmid">16760447</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>L</given-names></name><name><surname>Heathcote</surname><given-names>J</given-names></name><name><surname>Djurdjev</surname><given-names>O</given-names></name><name><surname>Levin</surname><given-names>A</given-names></name></person-group><article-title>Screening for renal disease using serum creatinine: who are we missing?</article-title><source>Nephrol Dial Transpl.</source><year>2001</year><volume>16</volume><issue>5</issue><fpage>1042</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1093/ndt/16.5.1042</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hommel</surname><given-names>K</given-names></name><name><surname>Madsen</surname><given-names>M</given-names></name><name><surname>Kamper</surname><given-names>A-L</given-names></name></person-group><article-title>The importance of early referral for the treatment of chronic kidney disease: a Danish nationwide cohort study</article-title><source>BMC Nephrol.</source><year>2012</year><volume>13</volume><fpage>108</fpage><pub-id pub-id-type="doi">10.1186/1471-2369-13-108</pub-id><pub-id pub-id-type="pmid">22963236</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Kusek</surname><given-names>JW</given-names></name><name><surname>Beck</surname><given-names>GJ</given-names></name></person-group><article-title>A simplified equation to predict glomerular filtration rate from serum creatinine</article-title><source>J Am Soc Nephrol</source><year>2000</year><volume>11</volume><fpage>155A</fpage></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockcroft</surname><given-names>DW</given-names></name><name><surname>Gault</surname><given-names>MH</given-names></name></person-group><article-title>Prediction of creatinine clearance from serum creatinine</article-title><source>Nephron.</source><year>1976</year><volume>16</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1159/000180580</pub-id><pub-id pub-id-type="pmid">1244564</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Eckardt</surname><given-names>K-U</given-names></name><name><surname>Tsukamoto</surname><given-names>Y</given-names></name><name><surname>Levin</surname><given-names>A</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Rossert</surname><given-names>J</given-names></name><etal/></person-group><article-title>Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)</article-title><source>Kidney Int</source><year>2005</year><volume>67</volume><issue>6</issue><fpage>2089</fpage><lpage>2100</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1755.2005.00365.x</pub-id><pub-id pub-id-type="pmid">15882252</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacGregor</surname><given-names>MS</given-names></name><name><surname>Taal</surname><given-names>MW</given-names></name></person-group><article-title>Renal Association Clinical Practice Guideline on detection, monitoring and management of patients with CKD</article-title><source>Nephron Clin Pract</source><year>2011</year><volume>118</volume><issue>Suppl 1</issue><fpage>c71</fpage><lpage>c100</lpage><pub-id pub-id-type="doi">10.1159/000328062</pub-id><pub-id pub-id-type="pmid">21555905</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbari</surname><given-names>A</given-names></name><name><surname>Swedko</surname><given-names>PJ</given-names></name><name><surname>Clark</surname><given-names>HD</given-names></name><name><surname>Hogg</surname><given-names>W</given-names></name><name><surname>Lemelin</surname><given-names>J</given-names></name><name><surname>Magner</surname><given-names>P</given-names></name><etal/></person-group><article-title>Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program</article-title><source>Arch Intern Med</source><year>2004</year><volume>164</volume><fpage>1788</fpage><lpage>1792</lpage><pub-id pub-id-type="doi">10.1001/archinte.164.16.1788</pub-id><pub-id pub-id-type="pmid">15364673</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>AK</given-names></name><name><surname>Cuerden</surname><given-names>MS</given-names></name><name><surname>McLeod</surname><given-names>I</given-names></name><name><surname>Hemmelgarn</surname><given-names>B</given-names></name><name><surname>Akbari</surname><given-names>A</given-names></name><name><surname>Tonelli</surname><given-names>M</given-names></name><etal/></person-group><article-title>Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD</article-title><source>Kidney Int</source><year>2012</year><volume>81</volume><fpage>1248</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1038/ki.2012.18</pub-id><pub-id pub-id-type="pmid">22437415</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>V</given-names></name><name><surname>Hammill</surname><given-names>BG</given-names></name><name><surname>Maciejewski</surname><given-names>ML</given-names></name><name><surname>Hall</surname><given-names>RK</given-names></name><name><surname>Scoyoc</surname><given-names>LV</given-names></name><name><surname>Garg</surname><given-names>AX</given-names></name><etal/></person-group><article-title>Impact of automated reporting of estimated glomerular filtration rate in the veterans health administration</article-title><source>Med Care</source><year>2015</year><volume>53</volume><issue>2</issue><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1097/MLR.0000000000000275</pub-id><pub-id pub-id-type="pmid">25415559</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3(Suppl): 1&#x02013;163.</mixed-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>M-J</given-names></name><name><surname>Shu</surname><given-names>K-H</given-names></name><name><surname>Liu</surname><given-names>P-H</given-names></name><name><surname>Chiang</surname><given-names>P-H</given-names></name><name><surname>Cheng</surname><given-names>C-H</given-names></name><name><surname>Chen</surname><given-names>C-H</given-names></name><etal/></person-group><article-title>High risk of renal failure in stage 3b chronic kidney disease is under-recognized in standard medical screening</article-title><source>J Chin Med Assoc.</source><year>2010</year><volume>73</volume><issue>10</issue><fpage>515</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1016/S1726-4901(10)70113-1</pub-id><pub-id pub-id-type="pmid">21051028</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><etal/></person-group><article-title>Underestimated incidence of kidney disease in nonrenal outpatient</article-title><source>Ren Fail</source><year>2017</year><volume>39</volume><issue>1</issue><fpage>328</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1080/0886022X.2017.1279551</pub-id><pub-id pub-id-type="pmid">28118757</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorente</surname><given-names>DG</given-names></name><name><surname>Lorente</surname><given-names>JG</given-names></name><name><surname>Usach</surname><given-names>TS</given-names></name></person-group><article-title>Repeated serum creatinine measurement in primary care: not all patients have chronic renal failure</article-title><source>Nefrologia.</source><year>2015</year><volume>35</volume><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.nefro.2015.06.020</pub-id><pub-id pub-id-type="pmid">26306952</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannapiran</surname><given-names>M</given-names></name><name><surname>Nisha</surname><given-names>D</given-names></name><name><surname>Madhusudhana</surname><given-names>Rao A</given-names></name></person-group><article-title>Underestimation of impaired kidney function with serum creatinine</article-title><source>Ind J Clin Biochem.</source><year>2010</year><volume>25</volume><issue>4</issue><fpage>380</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1007/s12291-010-0080-4</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labrador</surname><given-names>PJ</given-names></name><name><surname>Mengotti</surname><given-names>T</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>M</given-names></name><name><surname>Mac&#x000ed;as</surname><given-names>M</given-names></name><name><surname>Vicente</surname><given-names>F</given-names></name><name><surname>Labrador</surname><given-names>J</given-names></name><etal/></person-group><article-title>Occult renal failure in primary care. A women&#x02019;s problem?</article-title><source>Nefrolog&#x000ed;a.</source><year>2007</year><volume>27</volume><issue>6</issue><fpage>716</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">18336101</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swedko</surname><given-names>PJ</given-names></name><name><surname>Clark</surname><given-names>HD</given-names></name><name><surname>Paramsothy</surname><given-names>K</given-names></name><name><surname>Akbari</surname><given-names>A</given-names></name></person-group><article-title>Serum creatinine is an inadequate screening test for renal failure in elderly patients</article-title><source>Arch Intern Med</source><year>2003</year><volume>163</volume><issue>3</issue><fpage>356</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1001/archinte.163.3.356</pub-id><pub-id pub-id-type="pmid">12578517</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duru</surname><given-names>OK</given-names></name><name><surname>Vargas</surname><given-names>RB</given-names></name><name><surname>Kermah</surname><given-names>D</given-names></name><name><surname>Nissenson</surname><given-names>AR</given-names></name><name><surname>Norris</surname><given-names>KC</given-names></name></person-group><article-title>High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine</article-title><source>J Gen Intern Med</source><year>2008</year><volume>24</volume><issue>1</issue><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1007/s11606-008-0850-3</pub-id><pub-id pub-id-type="pmid">18987917</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannelli</surname><given-names>SV</given-names></name><name><surname>Patel</surname><given-names>KV</given-names></name><name><surname>Windham</surname><given-names>BG</given-names></name><name><surname>Pizzarelli</surname><given-names>F</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Guralnik</surname><given-names>JM</given-names></name></person-group><article-title>Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine</article-title><source>J Am Geriatr Soc</source><year>2007</year><volume>55</volume><fpage>816</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2007.01196.x</pub-id><pub-id pub-id-type="pmid">17537080</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigo</surname><given-names>MP</given-names></name><name><surname>Andr&#x000e9;s</surname><given-names>MR</given-names></name></person-group><article-title>Evaluation of hidden renal insufficiency by abbreviated-MRD equation</article-title><source>Nefrolog&#x000ed;a.</source><year>2006</year><volume>26</volume><issue>3</issue><fpage>339</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">16892822</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>F&#x000e1;cila</surname><given-names>L</given-names></name><name><surname>Bertomeu-Gonz&#x000e1;lez</surname><given-names>V</given-names></name><name><surname>Bertomeu</surname><given-names>V</given-names></name><name><surname>Gonz&#x000e1;lez-Juanatey</surname><given-names>JR</given-names></name><name><surname>Maz&#x000f3;n</surname><given-names>P</given-names></name><name><surname>Morillas</surname><given-names>P</given-names></name><collab>RICAR group</collab></person-group><article-title>Importance of recognizing occult renal disease in hypertensive patients</article-title><source>Rev Esp Cardiol.</source><year>2009</year><volume>62</volume><issue>3</issue><fpage>282</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/S0300-8932(09)70371-9</pub-id><pub-id pub-id-type="pmid">19268072</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>National Kidney Foundation</collab></person-group><article-title>K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification</article-title><source>Ann Intern Med</source><year>2002</year><volume>39</volume><issue>2</issue><fpage>S1</fpage><lpage>S266</lpage></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bostom</surname><given-names>AG</given-names></name><name><surname>Kronenberg</surname><given-names>F</given-names></name><name><surname>Ritz</surname><given-names>E</given-names></name></person-group><article-title>predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels</article-title><source>J Am Soc Nephrol</source><year>2002</year><volume>13</volume><fpage>2140</fpage><lpage>2144</lpage><pub-id pub-id-type="doi">10.1097/01.ASN.0000022011.35035.F3</pub-id><pub-id pub-id-type="pmid">12138147</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Bosch</surname><given-names>JP</given-names></name><name><surname>Lewis</surname><given-names>JB</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Rogers</surname><given-names>N</given-names></name><name><surname>Roth</surname><given-names>D</given-names></name></person-group><article-title>A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group</article-title><source>Ann Intern Med.</source><year>1999</year><volume>130</volume><issue>6</issue><fpage>461</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-130-6-199903160-00002</pub-id><pub-id pub-id-type="pmid">10075613</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Stevens</surname><given-names>LA</given-names></name></person-group><article-title>Kidney function estimating equations: where do we stand?</article-title><source>Curr Opin Nephrol Hypertens</source><year>2006</year><volume>15</volume><fpage>276</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1097/01.mnh.0000222695.84464.61</pub-id><pub-id pub-id-type="pmid">16609295</pub-id></element-citation></ref></ref-list></back></article>